Table 1.
Active TBS (n=25) | Sham TBS (n=25) | p valuea | |
---|---|---|---|
Demographic Variables | |||
Age (years, SD) | 48.6 (12.8) | 53.2 (11.6) | 0.19 |
Sex, N (%) female | 5 (20) | 3 (12) | 0.44 |
Race, n (%)b | 0.35 | ||
Caucasian/White | 22 (88) | 20 (80) | |
African American | 0 (0) | 2 (8) | |
American Indian/Alaskan Native | 1 (4) | 0 (0) | |
Multiracial | 2 (8) | 1 (4) | |
Ethnicity, n (%)b | 0.37 | ||
Hispanic origin | 0 (0) | 2 (8) | |
Not of Hispanic origin | 23 (92) | 23 (92) | |
Education, n (%)b | 0.15 | ||
Less than high school | 1 (4) | 1 (4) | |
High school or equivalent | 2 (8) | 5 (20) | |
Some college | 11 (44) | 7 (28) | |
Trade or vocational degree | 3 (12) | 0 (0) | |
Bachelor’s degree | 2 (8) | 8 (32) | |
Advanced degree and/or education beyond college | 2 (8) | 3 (12) | |
Employment status, n (%)b | 0.80 | ||
Full time | 6 (24) | 4 (16) | |
Part time | 1 (4) | 2 (8) | |
Unemployed | 10 (40) | 9 (36) | |
Retired | 6 (24) | 9 (36) | |
Service connected disability, n (%) approved for mental health | 14 (56) | 17 (68) | |
Military History | |||
Branch, n (%)b | 0.61 | ||
Army | 8 (32) | 8 (32) | |
Navy | 8 (32) | 6 (24) | |
Marines | 2 (8) | 1 (4) | |
Air Force | 0 (0) | 3 (12) | |
Clinical Variables (mean, SD) | |||
PTSD CAPS-5 Score | 47.4 (10.6) | 47.9 (10.0) | 0.85 |
PTSD PCL-5 Score | 49.4 (9.4) | 50.0 (11.4) | 0.85 |
Psychiatric Comorbidity, n (%) | 47.4 (10.6) | 47.9 (10.0) | 0.80 |
Major Depressive Disorderc | 25 (100) | 25 (100) | 1.00 |
Bipolar II, most recent episode depressed | 2 (8) | 3 (12) | 0.64 |
Substance Use Disorder (Mild) | 16 (64) | 11 (44) | 0.16 |
Opioid use disorder | 6 (24) | 5 (20) | 0.73 |
Prior brain stimulation, n (%) | |||
Transcranial Magnetic Stimulation | 0 (0) | 2 (8) | 0.15 |
Electroconvulsive Therapy | 2 (8) | 1 (4) | 0.55 |
Mild traumatic brain injury, n (%) | 7 (28) | 5 (20) | 0.51 |
Psychiatric History, n (%) | |||
Suicide attempt(s) | 6 (24) | 6 (24) | 1.00 |
Inpatient hospitalization(s) | 13 (52) | 15 (64) | 0.57 |
DAR (mean, SD) | |||
Baseline | 11.5 (6.3) | 14.1 (5.6) | 0.13 |
Midpoint double blind | 9.1 (6.3) | 13.2 (5.5) | 0.02 |
Endpoint double blind | 9.4 (6.6) | 12.7 (5.9) | 0.07 |
Midpoint open label | 8.8 (6.8) | 11.6 (6.5) | 0.14 |
Endpoint open label | 7.8 (6.8) | 9.3 (6.5) | 0.41 |
Follow-up | 8.2 (6.5) | 10.9 (6.9) | 0.17 |
PSQI (mean, SD) | |||
Baseline | 14.0 (2.9) | 13.8 (4.7) | 0.86 |
Midpoint double blind | 11.7 (4.0) | 12.8 (4.3) | 0.34 |
Endpoint double blind | 11.3 (3.9) | 12.6 (4.8) | 0.31 |
Midpoint open label | 10.6 (3.7) | 12.1 (4.9) | 0.26 |
Endpoint open label | 10.2 (3.6) | 11.1 (5.1) | 0.54 |
Follow-up | 9.5 (3.3) | 10.2 (4.8) | 0.58 |
Abbreviations: SD, Standard deviation; PTSD, posttraumatic stress disorder; CAPS-5, Clinician Administered PTSD Scale for DSM-5; PCL-5, PTSD Checklist for DSM-5. DAR, Dimensions of Anger Reactions scale; PSQI, Pittsburgh Sleep Quality Index.
p values represent between group contrast at baseline
Total < 100% due to participant non-response
Score of ≥ 14 on the 30-Item Inventory of Depressive Symptomology, Self-Report (IDS-SR)
p values represent independent samples t-test between groups.